Of interest, analysis of RNA-seq data and corresponding patient clinical information of the TCGA-SKCM of 98 melanoma patients demonstrated a positive correlation between increased CX3CR1 levels and increased overall survival probability in the melanoma patients, along with a discernible CD8+ T cell signature (Figure 3). The gene discussed is CX3CR1; the disease is melanoma.